#EHJOpen Editor-in-Chief official X account. Posts by Prof Magnus Bäck and his team. #OpenUpYourScience
Joined March 2021
- Tweets1.3K
- Following120
- Followers1.1K
- Likes1.9K
Pinned Tweet
Read this month's Editor choice:
Creatinine compared to Cystatin C: impact on Clinical Outcomes in #AtrialFibrillation
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78 @SilCastelletti academic.oup.com/ehjopen/art…
#OpenUpYourScience with #EHJOpen: check the latest data on Congenital Heart Disease!
Transition from Paediatric to Adult Congenital Heart Disease Care is not Just a challenge, but a real opportunity to improve the care of our patients!
#OpenUpYourScience
@ESC_Lavinia @ProfMagnusBack
@WGACHDChair @saramoscatelli7 academic.oup.com/ehjopen/art…
EHJOpen Editor-in-Chief retweeted
Semaglutide protects the heart but we still don't fully know how. #SELECT mediation analysis: classic risk factors explain only half the benefit. Read more in #EHJ.
doi.org/10.1093/eurheartj/eh…
#cardiotwitter @ESC_Journals @escardio
EHJOpen Editor-in-Chief retweeted
Left Ventricular Assist Device: Balancing Technological Excellence and Therapeutic Challenges!
#EHJ #heart #failure #mechanical #pump #cardiotwitter @ESC_Journals @escardio
ow.ly/TzNO50ZRRmw
EHJOpen Editor-in-Chief retweeted
Celebrating world heart day at @SCAI I3 mumbai meeting in India- the butter chicken and paneer will do wonders for my cv risk 😜😜
Not all ectopy carries the same weight—chamber-specific risk assessment is key in #ACHD!
Read the latest data published in #EHJOpen simultaneously with its presentation at #ESCCongress! 🫀 #Arrhythmia #CardioTwitter
@ESC_Lavinia @ProfMagnusBack @SaDeRosa78
doi.org/10.1093/ehjopen/oeag…
EHJOpen Editor-in-Chief retweeted
Lowering cumulative LDL-C exposure: the case for early treatment. Read more in EHJ.
doi.org/10.1093/eurheartj/eh…
#LDLC #CholesterolManagement #EarlyTreatment #LipidLowering #CardiovascularHealth #EHJ #Cardiology @escardio @ESC_Journals
EHJOpen Editor-in-Chief retweeted
The new 2026 ESC Guidelines for the management of cardiovascular disease and chronic kidney disease are now available on EHJ. In collaboration with the European Renal Association (ERA): Developed by the task force on the management of cardiovascular disease and chronic kidney disease of the European Society of Cardiology (ESC).
doi.org/10.1093/eurheartj/eh…
#ESC2026Guidelines #CardiovascularHealth #ChronicKidneyDisease #MedicalGuidelines2026 #CardioRenalCare @escardio @ESC_Journals
EHJOpen Editor-in-Chief retweeted
Did you pack your sport apparel in your suitcase to the #ESCCongress? Take a look at this month's Editor choice on #EHJOpen: association of self-reported sports volume and discipline with atrial arrhythmia prevalence in middle-aged males
@ESC_Lavinia
academic.oup.com/ehjopen/art…
Did you pack your sport apparel in your suitcase to the #ESCCongress? Take a look at this month's Editor choice on #EHJOpen: association of self-reported sports volume and discipline with atrial arrhythmia prevalence in middle-aged males
@ESC_Lavinia
academic.oup.com/ehjopen/art…
EHJOpen Editor-in-Chief retweeted
After all, a non-inferiority margin is just another imaginary line... CHAMPION-AF and CLOSURE-AF reconciled #LAAC: read the viewpoint in #EHJ
CHAMPION-AF and CLOSURE-AF: reconciling contrasting results. Read this viewpoint about left atrial appendage closure #LAAC in #EHJ
👉 ow.ly/1HrK50ZFXkg
@RoccoMontone @ehj_ed
EHJOpen Editor-in-Chief retweeted
#ACE inhibitors or #ARBs in #patients at high or very high #cardiovascular risk without #heartfailure: is the answer obvious?
Great collaboration on this Editorial in #EHJOpen of @escardio with @CarlLavie31733 💪
@ehjopen @SaDeRosa78
academic.oup.com/ehjopen/art…
Advance articles reinforce our commitment to rigorous, transparent, and fully accessible cardiovascular science.
Read the latest on intracoronary imaging: academic.oup.com/ehjopen/adv…
#OpenUpYourScience
@ESC_Lavinia @ProfMagnusBack @SaDeRosa78
Can the benefit of IVUS-guided PCI be influenced by how the angiography control arm is optimized?
We explored a “hidden IVUS effect” in contemporary trials.
#IVUS may shape modern #PCI even when not directly used.
academic.oup.com/ehjopen/adv…
@SaDeRosa78 @DaniTore74 @Y_Abdelwahed
The ESC journal family continues to grow in quality and reach with a special milestone: #EHJOpen has received its first IF: a strong signal for the authors who trust our mission.
Proud to stand alongside all ESC journals advancing rigorous, global research.
#OpenUpYourScience
2025 Impact Factors just released!
Congratulations to the Editors-in-Chief and their teams for their outstanding contribution to the @ESC_Journals Family. This year highlights the exceptional performance of the European Heart Journal, as well as the first Impact Factor for EHJ – Open, marking an important milestone.
Discover our new Impact Factors ow.ly/k2ml50ZfSZw
@RoccoMontone @ehj_ed @ehjopen #EHJ #EHJOpen
Remarkable result from Clarivate: #OpenUpYourScience with #EHJOpen!
Proud to share #EHJOpen's first IF: 4.3.
A remarkable step for a young journal built on quality, transparency, and a strong commitment to Open Science. Grateful to be part of this journey, excited for what’s ahead.
#OpenUpYourScience
@ESC_Lavinia @maciejbanach @maciejbanach
EHJOpen Editor-in-Chief retweeted
#EHJOpen's first Impact Factor is 4.3!
A milestone that reflects rigorous science, transparent processes, and the strength of our global CV community that motivates us to advancing high‑quality #OpenAccess research.
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78
#EHJOpen's first Impact Factor is 4.3!
A milestone that reflects rigorous science, transparent processes, and the strength of our global CV community that motivates us to advancing high‑quality #OpenAccess research.
#OpenUpYourScience
@ESC_Journals @ProfMagnusBack @SaDeRosa78
EHJOpen Editor-in-Chief retweeted
#OpenUpYourScience with #EHJOpen!
📊 Is it time to stop blood thinners after successful #Ablation for #AFib? New pooled data shows OAC discontinuation after significantly reduces major bleeding without increasing thromboembolic risk— & what about higher-risk patients? #CardioTwitter @VuMedi @ehjopen
Discontinuing oral anticoagulants post-successful #AFib #ablation. The data is out there: lower risk of major bleeding and no sign of increased thromboembolic events.
Full-paper now available in @ehjopen
academic.oup.com/ehjopen/art…
#EPeeps
#EHJ Open continues its upward trajectory!
Our Scopus CiteScore has risen to 5.6, a testament to the quality and the engagement of the CV research community.
A big thank you to all authors, @ProfMagnusBack, @ESC_Journals and to @OUPAcademic that made all this possible!
@Scopus